中文名稱：兔抗SNCA (Phospho-Tyr125) 多克隆抗體

英文名稱： Anti-SNCA (Phospho-Tyr125) rabbit polyclonal antibody

別名： PD1; NACP; PARK1; PARK4

相關(guān)類別：一抗

儲(chǔ) 存： 冷凍（-20℃）避光

宿主： Rabbit

抗原： SNCA (Phospho-Tyr125)

反應(yīng)種屬： Human

標(biāo) 記物： Unconjugate

克隆類型： rabbit polyclonal

技術(shù)規(guī)格

Background:

SncA is a member of the synuclein family of structurally related proteins that are prominently expressed in the central nervous system, which also includes beta- and gamma-synuclein. Synucleins are abundantly expressed in the brain and SncA and Snc-Beta inhibit phospholipase D2 selectively. SncA may serve to integrate presynaptic signaling and membrane trafficking. Aggregated SncA proteins form brain lesions that are hallmarks of neurodegenerative synucleinopathies. Defects in SncA play a role in the pathogenesis of Parkinson disease. SncA peptides are a major component of amyloid plaques in the brains of patients with Alzheimer disease. SncA shares 95% sequence homology with rat SncA. Rat SncA is specifically expressed in brain and is associated with synaptosomal membranes in neurons

Applications:

WB, IF

Name of antibody:

SNCA (Phospho-Tyr125)

Immunogen:

Synthetic peptide of human SNCA (Phospho-Tyr125)

Full name:

synuclein, alpha (non A4 component of amyloid precursor) (Phospho-Tyr125)

Synonyms：

PD1; NACP; PARK1; PARK4

SwissProt:

P37840

WB Predicted band size:

18 kDa

WB Positive control:

C2C12 cells treated with Anisomycin

WB Recommended dilution:

500-1000

IF Positive control:

Hela cells

IF Recommended dilution

100-200

展開全部

兔抗SNCA (Phospho-Tyr125) 多克隆抗體說(shuō)明書
下載

久久综合九九-久久综合九九亚洲一区-久久综合九色-久久综合九色欧美综合狠狠-久久综合九色婷婷97-久久综合九色综合8888

021-54845833/15800441009

ELISA試劑盒

PCR試劑盒

生化試劑盒

細(xì)胞系

細(xì)胞庫(kù)

基礎(chǔ)培養(yǎng)基

完全培養(yǎng)基

原代細(xì)胞

細(xì)胞專用培養(yǎng)基

菌株

生化試劑

病理染色液

科研抗體

標(biāo)準(zhǔn)品

血清

產(chǎn)品中心

最新產(chǎn)品

相關(guān)文章

兔抗SNCA (Phospho-Tyr125) 多克隆抗體

Background:	SncA is a member of the synuclein family of structurally related proteins that are prominently expressed in the central nervous system, which also includes beta- and gamma-synuclein. Synucleins are abundantly expressed in the brain and SncA and Snc-Beta inhibit phospholipase D2 selectively. SncA may serve to integrate presynaptic signaling and membrane trafficking. Aggregated SncA proteins form brain lesions that are hallmarks of neurodegenerative synucleinopathies. Defects in SncA play a role in the pathogenesis of Parkinson disease. SncA peptides are a major component of amyloid plaques in the brains of patients with Alzheimer disease. SncA shares 95% sequence homology with rat SncA. Rat SncA is specifically expressed in brain and is associated with synaptosomal membranes in neurons
Applications:	WB, IF
Name of antibody:	SNCA (Phospho-Tyr125)
Immunogen:	Synthetic peptide of human SNCA (Phospho-Tyr125)
Full name:	synuclein, alpha (non A4 component of amyloid precursor) (Phospho-Tyr125)
Synonyms：	PD1; NACP; PARK1; PARK4
SwissProt:	P37840
WB Predicted band size:	18 kDa
WB Positive control:	C2C12 cells treated with Anisomycin
WB Recommended dilution:	500-1000
IF Positive control:	Hela cells
IF Recommended dilution	100-200